BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Citius Pharmaceuticals Receives FDA Approval for LYMPHIR™ (denileukin diftitox-cxdl) Immunotherapy for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma

  August 8, 2024

   · 

  19 min read
• Press Releases

  Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion

  August 8, 2024

   · 

  24 min read
• Press Releases

  Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

  August 8, 2024

   · 

  16 min read
• Press Releases

  Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

  August 8, 2024

   · 

  13 min read
• Press Releases

  Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024

  August 8, 2024

   · 

  1 min read
• Press Releases

  Ocugen Provides Business Update with Second Quarter 2024 Financial Results

  August 8, 2024

   · 

  11 min read
• Press Releases

  Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

  August 8, 2024

   · 

  5 min read
• Press Releases

  HLS Therapeutics Announces Q2 2024 Financial Results

  August 8, 2024

   · 

  18 min read
• Business

  Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

  August 8, 2024

   · 

  16 min read
• Business

  Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

  August 8, 2024

   · 

  12 min read